Ddx20 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Ddx20 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox-protein
| protein_name = DEAD-Box Helicase 20 (Gemin3)
| gene = DDX20
| uniprot = Q9U5Q2
| pdb_ids = 4PMW, 4PMV
| molecular_weight = ~87 kDa
| subcellular_localization = Nucleus, Cytoplasm
| protein_family = DEAD-box helicase family
}}
ATP7A is a copper-transporting P-type ATPase that plays essential roles in copper homeostasis. For detailed information about its structure, function, and role in disease, refer to the main sections of this article.
¶ Domain Architecture
- N-terminal domain with multiple repeats
- Two RecA-like helicase domains ( helicase core)
- C-terminal domain
- Contains nine conserved motifs characteristic of DEAD-box helicases
- ATP-binding motif (Walker A)
- ATP-hydrolysis motif (Walker B)
- DEAD box sequence motif (Asp-Glu-Ala-Asp)
- Flexible C-terminal tail for protein interactions
- Forms complexes with other SMN complex proteins
- ATP-dependent RNA helicase
- Unwinds short RNA duplexes (20-25 bp)
- Does not require unwinding of long duplexes
- Uses ATP hydrolysis for conformational changes
- Modulates RNA-RNA and RNA-protein interactions
- Essential component of the SMN complex
- Required for snRNP (small nuclear ribonucleoprotein) assembly
- Critical for spliceosome biogenesis
- Facilitates the assembly of the heptameric Sm rings on snRNA
- Participates in the regeneration of snRNPs
- Associates with the Sin3A histone deacetylase complex
- Acts as a transcriptional co-repressor
- Modulates activity of various transcription factors
- Regulates p53-mediated transcription
- Functions in pre-mRNA splicing
- Affects alternative splicing patterns
- Involved in RNA transport
- Participates in ribosome biogenesis
- DDX20 is implicated in ALS pathogenesis
- The SMN complex function is altered in ALS
- Dysregulation of snRNP assembly contributes to RNA processing defects
- Interacts with ALS-related proteins (FUS, SMN)
- Motor neurons are particularly vulnerable to DDX20 dysfunction
- The SMN complex is deficient in SMA
- DDX20 plays an essential role in SMN complex function
- snRNP assembly is impaired in SMA
- Therapeutic strategies targeting SMN may improve DDX20 function
- DDX20 acts as a tumor suppressor in some contexts
- Regulates p53-dependent apoptosis
- Altered expression in various cancers
- May be a prognostic marker
- DDX20 is not currently a direct therapeutic target
- Understanding its role in SMN complex function may inform SMA therapies
- Research is ongoing to understand DDX20's role in neurodegeneration
- Developing DDX20 activity modulators
- Understanding protein-protein interactions
- Exploring DDX20 as a biomarker
- Mourelatos et al., Gemin3 defines a novel nuclear protein complex (2002)
- Liu et al., Structural basis for DDX20 function (2014)
- Burchell et al., DDX20 in cancer and p53 signaling (2013)
Ddx20 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
- Charroux B, et al. DDX20 in neuronal function. J Neurosci. 2010;30(45):15110-15120. PMID:21068313